|
Is
the pubic really pushing for this vaccine, or is the
government eager to use a product that it just
purchased for nearly $1 billion?
Washington Post March 30, 2002, pg. A02
| COMMENT By Dr. Sherri
Tenpenny: |
|
Does the idea of a European drug company
"donating" $150 million dollars worth of product as
an "insurance policy" for the American people sound
a bit suspicious? Five months of "secret
negotiations" were engaged prior to this decision.
Why did an act of charity necessitate "secret"
discussions? Was this an act of generous altruism or
did the company get something substantial in return?
It appears that Aventis may be the winner here.
One significant assurance negotiated in the favor of
the drug company was relief from product liability.
When testing begins, Aventis will be immune from any
lawsuits that may arise in the wake of side effects.
In addition, Aventis has been given the green
light to enter the US smallpox vaccine market. A
press release posted on the Aventis website at the
same time as the public announcement of the donation
states that Aventis will begin producing a new
smallpox vaccine using its proprietary, highly
attenuated vaccinia virus, called NYVAC™. The
company stated that, "the NYVAC approach could
potentially be used as a next generation smallpox
vaccine, should a broader immunization effort be
contemplated." If the old stuff doesn't work, there
is "new stuff" in the pipeline.
Aventis can now compete directly with Acambis,
another European vaccine manufacturer. Acambis was
rewarded two US Government contracts totaling $771
million to develop 209 million doses of smallpox
vaccine by the end of 2002. The amount of funds
allocated toward Aventis' new vaccine project was
undisclosed. However, it would be interesting to
know if the dollar amount of product donated to the
US will be off set by a promise to purchase an
equivalent amount ($150M) of the new vaccine, once
it becomes available.
The article reports that the Bush Administration
is "facing growing public pressure" to reevaluate
its position on mass vaccination. Is the pubic
really pushing for this vaccine, or is the
government eager to use a product that it just
purchased for nearly $1 billion?
In addition, the Washington Post article reports
that Vice President Cheney, Homeland Security
Director Tom Ridge and a few other select Pentagon
officials are "developing protocols" to determine
who should be inoculated. Note that the people
making these decisions are not involved with health
care. They are not physicians -- -they are business
men!!
The article goes on to state that the "task force
at the CDC" is scheduled to convene in May. This
group, called the Advisory Committee on Immunization
Practices (ACIP), is the panel of "experts" who make
recommendations regarding the use of vaccines. Its
membership is nearly all medical doctors and the
suggestions put forth by this group are for the most
part, universally accepted and implemented.
However, the committee's chairman, Dr. John
Modlin, Professor of Pediatrics and Medicine
Dartmouth Medical School, admits that in the case of
smallpox, the final suggestions made by ACIP may be
overridden. He states that, "the final decision [to
mass vaccinate] might be made by Mr. Thompson or
President Bush.
This public policy decision could result in
disaster.
Many articles in both medical journals and the
popular press have warned that the smallpox vaccine
can have severe, even lethal, side effects.
Considered to be "rare," these serious complications
are mostly dismissed. However, the Smallpox
Consensus Statement published in a 1999 JAMA article
reveals that "if 1 million persons were vaccinated,
as many as 250 persons would experience adverse
reactions that would require the administration of
VIG [vaccinia immune globulin.]"
Notably, this antidote is only used in cases of
severe vaccine reactions. Doing the math, that's 1
severe reaction in every 4000 vaccinations.
Considering that the CDC's mandatory Vaccine
Information Sheets (VIS)-which are required by law
to be given with each vaccine-state that severe
reactions are "rare" or "as seldom as 1 in a
million," the acknowledgment of a possible severe
reaction rate of 1 in 4000 is extremely significant.
There are six different known complications and
side effects associated with the smallpox vaccine.
The most serious complication, post-vaccine
encephalitis, can result in neurological damage or
death. There is no treatment for this side effect
and VIG is ineffective. Data taken from a 1968 CDC
report reveals that this type of reaction was
observed in 1 in 300,000 vaccines. This means that
if 250 million people were vaccinated, there would
be 833 cases of post-vaccine encephalitis related
brain damage or death. Apparently, that is the
government's definition of "rare." Compare this to
the recently recalled drug, Baycol, which was
removed from the market because it was linked to 52
deaths.
A second known vaccine complication is vaccinia
gangrenosa. This side effect begins when the initial
vaccine site fails to heal. A progressive necrosis,
or decay, of the skin adjacent to the vaccination
site develops, subsequently spreading to nearby
bones and then to internal organs. This severe
vaccine reaction also is frequently fatal.
The other types of non-lethal vaccine
complications include 1) vaccine-induced eczema, 2)
inadvertent auto-innoculation from the original
vaccine site to other locations, and 3) "generalized
vaccinia", which is essentially a mild case of
"smallpox." In addition, there are many different
vaccine-induced rashes reported including erythema
multiforme, a type of rash associated with
autoimmune problems. This suggests that the vaccine
can cause ongoing immune system disruption.
Considering that the chance of a smallpox attack
is highly speculative, is it worth potentially
killing or harming hundreds of people to protect the
nation against a "threat" that may not materialize?
The only known treatment for smallpox vaccine
complications is vaccinia immune globulin (VIG). VIG
is made from the serum of those who have been
vaccinated with the smallpox vaccine. Since smallpox
vaccination ceased in 1972, the supply of VIG is
severely limited.
The article states that "over the next six to
eight weeks, the NIH will conduct clinical trials on
the [frozen] Aventis vaccine and then perform
dilution tests." These investigations will serve a
dual purpose:
(1) test for side effects and reactions, since
the vaccine has never been tested in humans and
(2) create a pool of people with antibodies to
these vaccines, so that VIG can be "harvested" for
use when the mass vaccination program begins.
Based on these recent developments, it appears
that mass vaccination of the citizens of the United
States may be eminent, as everything is falling in
to place:
-The Model State Emergency Health Powers Act,
with its mandatory vaccination provisions, is
rolling through state legislatures, seemingly
unstoppable.
-Nearly $1billion has been awarded to Acambis,
Baxter and Aventis to bring the total supply of
smallpox vaccine to nearly 300 million doses by the
end of 2002, enough to fulfill HHS Secretary Tommy
Thompson's vision that "every man, woman and child
will have a vaccine with their name on it."
With these provisions in place, will we be able
to avoid vaccination if we choose?
And, if we DO choose to vaccinate, will we be
protected from smallpox? Mass smallpox vaccination
is designed to protect us in the event of a
bioterrorism attack. However, smallpox is one of
more than 65 available weapons of biological
warfare. The list includes viruses, bacteria, and
toxins. Here is a partial list:
VIRUSES
Congo-Crimean haemorrhagic fever virus
Dengue fever virus
Hantaan virus
Junin virus
Lassa fever virus virus
Ebola and other Marburg viruses
Monkeypox virus
BACTERIA
Coxiella burnetii (Q fever)
Brucella melitensis (Brucellosis)
Clostridium botulinum (Botuism)
Francisella tularensis (Tularemia)
TOXINS
Botulinum toxin
Clostridium toxin
Aflatoxins
Tetanus toxin
In addition, there are countless numbers of
agents that can be created through bioengineering
combinations of these organisms. In fact, the
smallpox virus itself can be engineered to contain
botuliunum toxin and other compounds. The smallpox
virus has been genetically engineered with the
following viruses here in U.S. labs: flu, herpes,
hepatitis B, rabies and HIV. None of the existing
smallpox vaccines would protect against these
combinations.
Upon analyzing this list, what is conspicuously
obvious is that vaccines are not available to
"protect" against most of these agents and many of
them are far more deadly than smallpox. The point is
that, even though smallpox (and anthrax) are
considered by the US government to be the "most
likely" biological warfare agents, perhaps the
media-generated hysteria surrounding mass
vaccination is simply because we HAVE a vaccine for
these two agents.
If you were a "terrorist", would smallpox be your
"bug of choice?"
Contact:
Address:
New Medical Awareness Seminars, LLC
c/o 13550 Falling Water Rd #202
Strongsville, Ohio 44136
Phone: 440-268-0897
Website:
www.osteomed.com |